This is beginning to get a little scary. On the day I submitted this article claiming that fears were already priced in, one of the big fears came true. Shares of Myriad Genetics (NASDAQ: MYGN) immediately tanked, If someone had read my article and bought the day of the knee-jerk reaction they would already be up nearly 20%.
I don't make these sort of investments myself. I can't stomach the volatility. I like to write about them because they get attention. I like to invest in wonderfully dull companies with steady predictable growth. This time I wish I had followed my advice.
No comments:
Post a Comment